Identification of novel biomarkers for diabetic retinopathy in tears

眼泪中糖尿病视网膜病变的新型生物标志物的鉴定

• 批准号: LP0669178
• 负责人: Prof Mark Willcox
• 金额: $ 12.11万
• 依托单位: The University of New South Wales
• 依托单位国家: 澳大利亚
• 项目类别: Linkage Projects
• 财政年份: 2006
• 资助国家: 澳大利亚
• 起止时间: 2006-07-01 至 2010-12-31
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/LP0669178
• 关键词: Identification; novel; biomarkers; diabetic; retinopathy

There are around 134,000 people with diabetic retinopathy in Australia. The disease affects patients' physical and mental state and economical and social cost is enormous. This research aims to find new biomarkers for the disease which may lead to better treatment and management. Patient's quality of life may be significantly improved by early diagnosis and treatment and the burden to the community reduced. This project also gives industrial partners the opportunity to develop new products to diagnose and monitor the disease.

澳大利亚约有 134,000 人患有糖尿病视网膜病变。该病影响患者的身心状态，经济和社会成本巨大。这项研究旨在寻找该疾病的新生物标志物，从而实现更好的治疗和管理。早期诊断和治疗可以显着改善患者的生活质量，并减轻社区的负担。该项目还为工业合作伙伴提供了开发新产品来诊断和监测疾病的机会。